Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer.

about

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer.

P2860

Q49834246-282603E1-02B7-48C8-A4D3-7ADFF9B649C5

P2860

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer.

Item

http://www.wikidata.org/entity/Q35744938

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@ast

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@en

type

Item

label

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@ast

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@en

prefLabel

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@ast

Aromatase Inhibitor-Induced Er ...... l Treatment for Breast Cancer.

@en

P1476

Aromatase Inhibitor-Induced Er ...... al Treatment for Breast Cancer

@en

P2093

Onyekachi Henry Ogbonna

http://www.w3.org/2001/XMLSchema#string

Patricia Oneal

http://www.w3.org/2001/XMLSchema#string

Sri Lakshmi Hyndavi Yeruva

http://www.w3.org/2001/XMLSchema#string

P2860

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis.

Managing aromatase inhibitors in breast cancer survivors: not just for oncologists

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

Long-term safety of aromatase inhibitors in the treatment of breast cancer.

A case of erythrocytosis in a patient treated with an aromatase inhibitor for breast cancer.

Higher androgen bioactivity is associated with excessive erythrocytosis and chronic mountain sickness in Andean Highlanders: a review.

Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.

Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men.

Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis)

P304

784783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/784783

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Stanley Madu Nwabudike

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279154959

http://www.w3.org/2001/XMLSchema#string

P698

26137331

http://www.w3.org/2001/XMLSchema#string

P932

4468297

http://www.w3.org/2001/XMLSchema#string

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer.

about

P2860

P2860

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932